Quick Answer
AVAI BIO, INC. reported Cash And Cash Equivalents At Carrying Value of $81.1 thousand for the year ending 2025.
- AVAI BIO, INC. showed an increase of +28,744.5% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from AVAI BIO, INC.'s annual report (Form 10-K), filed with the SEC on July 8, 2025.
- XBRL data for this metric is available from 2019 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 8 years of available data (2019 to 2025), AVAI BIO, INC.'s Cash And Cash Equivalents At Carrying Value has grown by 79,363.7%.
- Historical annual values: Fiscal year 2025: $81.1 thousand | Fiscal year 2024: $281.00 | Fiscal year 2023: $107.5 thousand | Fiscal year 2022: $33.3 thousand | Fiscal year 2021: $60.4 thousand | Fiscal year 2020: $27.3 thousand | Fiscal year 2020: $27.3 thousand | Fiscal year 2019: $102.00.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: